menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Nick Buschur takes over as CEO at blow-fill-seal CDMO Woodstock

    FIERCE PHARMA

    FDA Issues Form 483 to Patheon Italia S.p.A

    FDA

    Patheon`s Generic Ibuprofen Receives Approval in the U.S.

    FDA

    Patheon`s Generic Naproxen Sodium Receives Approval in the U.S.

    FDA

    Neuvivo Begins Manufacture of ALS Treatment NP001

    CONTRACTPHARMA

    Oxcia contracts Patheon for manufacturing & further strengthens the organization

    CISION

    Patheon to Manufacture FDA-Approved Nasal Spray

    CONTRACTPHARMA

    Tergus Pharma to become full-fledged CDMO with new manufacturing facility

    FIERCE PHARMA

    Thermo Fisher picks up mass spec software developer HighChem

    FIERCE BIOTECH

    Cantargia, Patheon Biologics Sign Supply Agreement

    CONTRACT PHARMA

    Overview of comments received on Ibuprofen 200 – 800 mg IR formulations

    EMA

    Enforcement Report - Week of March 14, 2018

    FDA

    Enforcement Report - Week of March 7, 2018

    FDA

    Naproxen Sodium : Patheon Softgels V. Apotex

    PATENT LITIGATION

    Evoke’s experience with Thermo wins Patheon nasal metoclopramide contract

    IN PHARMATECHNOLOGIST

    More than 100 CMOs fully configured on TraceLink Life Sciences Cloud

    MANUFACTURING CHEMIST

    Planning teams forming as Thermo Fisher completes $7.2bn Patheon acquisition

    OUTSOURCING

    Patheon joins Thermo Fisher with completion of $7.2B buyout

    FIERCE PHARMA

    Anvisa grants registration to drug Spinraza

    ANVISA

    Thermo Fisher Scientific receives regulatory approvals - acquisition of Patheon

    PHARMABIZ

    Generic Drugs Stock Performance Review Patheon, Zoetis, Ironwood & Medicines

    PR NEWSWIRE

    Thermo Fisher pulls in funding as it preps for Patheon acquisition

    OUTSOURCING PHARMA

    Patheon invests in 4 sites ahead of buyout by Thermo Fisher

    FIERCE PHARMA

    Patheon to spend $45m on manufacturing plants ahead of Thermo takeover

    IN PHARMATECHNOLOGIST

    Tetraphase hires Patheon to make its synthetic antibiotic eravacycline

    IN PHARMATECHNOLOGIST

    After Bagging Patheon for $7.2 Billion, This Could be Thermo Fisher Scientific

    BIOSPACE

    Patheon to manufacture amyloidosis antibody treatment for Caelum

    BIOPHARMA

    Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn

    IN PHRAMATECHNOLOGIST

    Patheon spends $26m to up capacity for liquid and freeze-dried drugs

    IN PHARMATECHNOLOGIST

    Patheon says buyout of Roche API plant gives it border tax protection

    FIERCE PHARMA

    Keryx: Patheon and Norwich sites will ensure supply of iron-based Auryxia

    IN PHARMATECHNOLOGIST

    Enforcement Report - Week of February 22, 2017

    FDA

    Teva recalls 500,000 units of diabetes drug manufactured by Patheon

    FIERCE PHARMA

    Is the return of the one-stop-shop model just a CMO marketing ploy?

    IN PHARMATECHNOLOGIST

    Roche: `Largest biomanufacturing capacity across the industry` to get bigger

    IN PHARMATECHNOLOGIST

    Patheon well placed if Trump succeeds in bringing manufacturing home, analyst

    IN PHARMATECHNOLOGIST

    Lonza Bulks up with $5.5B Deal for Capsugel

    FIERCE PHARMA

    Lonza Confirms Interest in Capsugel Takeover

    IN PHARMATECHNOLOGIST

    Roche to Sell U.S. Plant to Patheon, Saving About 200 Jobs

    FIERCE PHARMA

    Hurricane and fire related shutdowns have cost Patheon $15m

    IN PHARMATECHNOLOGIST

    Keryx solves supply issues as FDA approves Patheon to produce kidney drug

    FIERCE PHARMA

    Endo`s Par recalls half a million birth control pills made by Patheon

    FIERCE PHARMA

    Patheon Contracted to Make Second Drug by Age-Related Diseases Firm Biophytis

    IN PHARMATECHNOLOGIST

    Patheon Announces The Retirement Of Stuart Grant

    PRESS RELEASE

    Actavis recalls pills made by Patheon

    FIERCE MANUFACTURING

    API and drug maker Patheon will begin trading on the NYSE under the symbol PTHN

    IN PHARMATECHNOLOGIST

    Patheon Names Patrick Glaser Senior VP for Small Molecule API Business

    PRESS RELEASE

    Patheon Appoints Michel Lagarde As President

    PRESS RELEASE

    Flexible Manufacturing Can Help Pharmaceutical Industry Avoid High Costs

    PRESS RELEASE

    Patheon signs flexible manufacturing agreement with Amgen

    CPHI-ONLINE

    Patheon Customers saves time with new filling technology

    PRESS RELEASE

    Patheon Appoints Andrew G. Long as Senior VP & Global Business Controller

    PRESS RELEASE

    Patheon Appoints Leader for Biologics

    PRESS RELEASE

    Patheon Unveils New Brand and Identity

    PRESS RELEASE

    Expanding Patheon Begins Hiring Hundreds at Eastern North Carolina Plant

    BIOSPACE

    Patheon, DPx unload chemical operations to tighten focus on pharma

    FIERCE PHARMA MANUFACTURING

    Ardian Acquires Business From DPx Holdings B.V.

    PRESS RELEASE

    Patheon Expands Stability Testing Capabilities in Greenville, NC

    PRESS RELEASE

    DPx Buyout Of Specialty API Maker IRIX Is A Wrap

    FIERCE PHARMAMANUFACTURING

    Norway`s Weifa Bets Growth On Separate API Biz

    FIERCE PHARMA MANUFACTURING

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.